dc.contributor.author | Wagner, Theresa | |
dc.contributor.author | Janice, Jessin | |
dc.contributor.author | Sivertsen, Audun | |
dc.contributor.author | Sjögren, Ingegerd | |
dc.contributor.author | Sundsfjord, Arnfinn | |
dc.contributor.author | Hegstad, Kristin | |
dc.date.accessioned | 2021-01-23T14:09:32Z | |
dc.date.available | 2021-01-23T14:09:32Z | |
dc.date.issued | 2020-12-26 | |
dc.description.abstract | <i>Background</i> - Vancomycin variable enterococci (VVE) are <i>van</i>-positive isolates with a susceptible phenotype that can convert to a resistant phenotype during vancomycin selection.<p>
<p><i>Objectives</i> - To describe a vancomycin-susceptible <i>vanA</i>-PCR positive ST203 VVE <i>Enterococcus faecium</i> isolate (VVE<i>Swe</i>-S) from a liver transplantation patient in Sweden which reverted to resistant (VVE<i>Swe</i>-R) during <i>in vitro</i> vancomycin exposure.<p>
<p><i>Methods</i> - WGS analysis revealed the genetic differences between the isolates. Expression of the <i>van</i>-operon was investigated by qPCR. Fitness and stability of the revertant were investigated by growth measurements, competition and serial transfer.<p>
<i>Results</i> - The VVE<i>Swe</i>-R isolate gained high-level vancomycin (MIC >256 mg/L) and teicoplanin resistance (MIC = 8 mg/L). VVE<i>Swe</i>-S has a 5′-truncated <i>vanR</i> activator sequence and the VVE<i>Swe</i>-R has in addition acquired a 44 bp deletion upstream of <i>vanHAX</i> in a region containing alternative putative constitutive promoters. In VVE<i>Swe</i>-R the <i>vanHAX</i>-operon is constitutively expressed at a level comparable to the non-induced prototype <i>E. faecium</i> BM4147 strain. The <i>vanHAX</i> operon of VVESwe is located on an Inc18-like plasmid, which has a 3–4-fold higher copy number in VVE<i>Swe</i>-R compared with VVE<i>Swe</i>-S. Resistance has a low fitness cost and the vancomycin MIC of VVE<i>Swe</i>-R decreased during <i>in vitro</i> serial culture without selection. The reduction in MIC was associated with a decreased vanA-plasmid copy number.<p>
<p><i>Conclusions</i> - Our data support a mechanism by which vancomycin-susceptible VVE strains may revert to a resistant phenotype through the use of an alternative, constitutive, <i>vanR</i>-activator-independent promoter and a <i>vanA</i>-plasmid copy number increase. | en_US |
dc.identifier.citation | Wagner T, Janice JJ, Sivertsen A, Sjögren I, Sundsfjord A, Hegstad K. Alternative vanHAX promoters and increased vanA-plasmid copy number resurrect silenced glycopeptide resistance in Enterococcus faecium. Journal of Antimicrobial Chemotherapy. 2020 | |
dc.identifier.cristinID | FRIDAID 1865823 | |
dc.identifier.doi | 10.1093/jac/dkaa541 | |
dc.identifier.issn | 0305-7453 | |
dc.identifier.issn | 1460-2091 | |
dc.identifier.uri | https://hdl.handle.net/10037/20433 | |
dc.language.iso | eng | en_US |
dc.publisher | Oxford University Press | en_US |
dc.relation.journal | Journal of Antimicrobial Chemotherapy | |
dc.rights.holder | Copyright 2020 The Author(s) | en_US |
dc.subject | VDP::Medical disciplines: 700::Basic medical, dental and veterinary science disciplines: 710 | en_US |
dc.subject | VDP::Medisinske Fag: 700::Basale medisinske, odontologiske og veterinærmedisinske fag: 710 | en_US |
dc.title | Alternative vanHAX promoters and increased vanA-plasmid copy number resurrect silenced glycopeptide resistance in Enterococcus faecium | en_US |
dc.type.version | publishedVersion | en_US |
dc.type | Journal article | en_US |
dc.type | Tidsskriftartikkel | en_US |
dc.type | Peer reviewed | en_US |